Resultados da pesquisa - Ullenhag, Gustav
- A mostrar 1 - 20 resultados de 26
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
Clinical and Immune Effects of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer Por Ullenhag, Gustav J., Mozaffari, Fariba, Broberg, Mats, Mellstedt, Håkan, Liljefors, Maria
Publicado em 2017Text -
6
Tumoral Pyruvate Kinase L/R as a Predictive Marker for the Treatment of Renal Cancer Patients with Sunitinib and Sorafenib Por Niinivirta, Marjut, Enblad, Gunilla, Lindskog, Cecilia, Pontén, Fredrik, Dragomir, Anca, Ullenhag, Gustav J.
Publicado em 2019Text -
7
Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib Por Niinivirta, Marjut, Georganaki, Maria, Enblad, Gunilla, Lindskog, Cecilia, Dimberg, Anna, Ullenhag, Gustav J.
Publicado em 2020Text -
8
Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib Por Niinivirta, Marjut, Enblad, Gunilla, Edqvist, Per-Henrik, Pontén, Fredrik, Dragomir, Anca, Ullenhag, Gustav J.
Publicado em 2017Text -
9
-
10
Improved survival without increased toxicity with influenza vaccination in cancer patients treated with checkpoint inhibitors Por Valachis, Antonios, Rosén, Camilla, Koliadi, Anthoula, Digkas, Evangelos, Gustavsson, Alice, Nearchou, Andreas, Ullenhag, Gustav J
Publicado em 2021Text -
11
Socioeconomy as a prognostic factor for location of death in Swedish palliative cancer patients Por Nilsson, Jonas, Holgersson, Georg, Ullenhag, Gustav, Holmgren, Malin, Axelsson, Bertil, Carlsson, Tobias, Bergqvist, Michael, Bergström, Stefan
Publicado em 2021Text -
12
Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients Por Schiza, Aglaia, Irenaeus, Sandra, Ortiz-Nieto, Francisco, Loskog, Angelica, Tötterman, Thomas, Sundin, Anders, Ullenhag, Gustav J., Ahlström, Håkan
Publicado em 2019Text -
13
Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma Por Tholander, Bengt, Koliadi, Anthoula, Botling, Johan, Dahlstrand, Hanna, Von Heideman, Anne, Ahlström, Håkan, Öberg, Kjell, Ullenhag, Gustav J.
Publicado em 2020Text -
14
Immune priming using DC- and T cell-targeting gene therapy sensitizes both treated and distant B16 tumors to checkpoint inhibition Por Wenthe, Jessica, Naseri, Sedigheh, Hellström, Ann-Charlotte, Moreno, Rafael, Ullenhag, Gustav, Alemany, Ramon, Lövgren, Tanja, Eriksson, Emma, Loskog, Angelica
Publicado em 2022Text -
15
Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay Por Blokzijl, Andries, Chen, Lei E., Gustafsdottir, Sigrun M., Vuu, Jimmy, Ullenhag, Gustav, Kämpe, Olle, Landegren, Ulf, Kamali-Moghaddam, Masood, Hedstrand, Håkan
Publicado em 2016Text -
16
Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients Por Loskog, Angelica, Maleka, Aglaia, Mangsbo, Sara, Svensson, Emma, Lundberg, Christina, Nilsson, Anders, Krause, Johan, Agnarsdóttir, Margrét, Sundin, Anders, Ahlström, Håkan, Tötterman, Thomas H, Ullenhag, Gustav
Publicado em 2016Text -
17
Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients Por Irenaeus, Sandra, Schiza, Aglaia, Mangsbo, Sara M., Wenthe, Jessica, Eriksson, Emma, Krause, Johan, Sundin, Anders, Ahlström, Håkan, Tötterman, Thomas H., Loskog, Angelica, Ullenhag, Gustav J.
Publicado em 2017Text -
18
Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial Por Olofsson, Roger, Ny, Lars, Eilard, Malin Sternby, Rizell, Magnus, Cahlin, Christian, Stierner, Ulrika, Lönn, Ulf, Hansson, Johan, Ljuslinder, Ingrid, Lundgren, Lotta, Ullenhag, Gustav, Kiilgaard, Jens Folke, Nilsson, Jonas, Lindnér, Per
Publicado em 2014Text -
19
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study Por Jespersen, Henrik, Olofsson Bagge, Roger, Ullenhag, Gustav, Carneiro, Ana, Helgadottir, Hildur, Ljuslinder, Ingrid, Levin, Max, All-Eriksson, Charlotta, Andersson, Bengt, Stierner, Ulrika, Nilsson, Lisa M., Nilsson, Jonas A., Ny, Lars
Publicado em 2019Text -
20
Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM... Por Naeser, Ylva, Helgadottir, Hildur, Hansson, Johan, Ingvar, Christian, Elander, Nils O., Flygare, Petra, Nilsson, Cecilia, Jakobsson, Frida, Valachis, Antonios, Papantoniou, Dimitrios, Nordin Danfors, Agneta, Johansson, Hemming, Sundin, Anders, Brandberg, Yvonne, Ullenhag, Gustav J.
Publicado em 2022Text